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Abstract Manipulating the selectivity of Baeyer-Villiger (BV) reactions is an ongoing research challenge in organic chemistry. Generally relying on hazardous heavy metals and harsh reaction conditions, only a few chemical catalysts are enantioselective, while deliberate production of the so-called abnormal BV product is virtually impossible by chemical means. Biocatalysis using BV monooxygenases does not face these limitations, as the specificity of enzymes can be tuned by directed evolution. Here, we applied iterative saturation mutagenesis at sites lining the binding pocket of a thermostable cyclohexanone monooxygnease to alter its natural selectivity. We determined the enzyme’s scope on substituted cyclic ketones and switched the enantioselectivity for 2-methylcyclohexanone from 99% ee S to 94% ee R. We then aimed to also switch regioselectivity, and challenged our method by using three linear ketones as substrates, which are inherently prone to produce the normal product. We were able to reverse the regioselectivity with 4-phenyl-2-butanone from 99:1 in favor of the normal 2-phenylethyl migration to 2:98 in favor of methyl migration. The reversal of regioselectivity was also achieved in the BV reaction of two other linear ketones. We determined the kinetic parameters of the wild-type and best mutant enzymes for the studied reactions and also confirmed that the mutations did not affect thermostability. A computational analysis using MD simulations shed light on the enantioselectivity switch, but suggested that quantum mechanic effects need to be taken into account. An extended methodology was thus applied to study the regioselectivity switch, and we found a combination of induced changes in the conformation of the Criegee intermediates and crucial (de)stabilizations of transition states to dictate selectivities. The enzyme can thereby override electronic control, which normally causes preferential migration of the group that is best able to stabilize positive charge.     
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Introduction The Baeyer-Villiger oxidation of ketones or aldehydes is a valuable transformation in synthetic organic chemistry in which a single oxygen atom is inserted into the C–C bond adjacent to a carbonyl moiety with formation of esters or lactones.1-4 Many different reagents such as peracids or hydroperoxides have been used as stoichiometric oxidants, sometimes in the presence of chiral transition metal catalysts5-12 or organocatalysts13-17 for obtaining enantiomerically enriched or pure products. The C–C activating process can also be catalyzed by Baeyer-Villiger monooxygenases (BVMOs),18-24 which require only dioxygen from air, thereby avoiding the use of potentially explosive reagents. Mechanistically, O2 reacts with the reduced form of the enzyme-bound flavin (FAD), brought into this redox state by NADPH, with formation of an intermediate flavin peroxide. This intermediate in the anionic form adds to the carbonyl function leading to the so-called Criegee intermediate. In the final step, one of the alkyl or aryl groups next to the original carbonyl function migrates. The product is then released, after which NADP+ is also released. Being NADPH-dependent, BVMOs require a cofactor regeneration system such as glucose dehydrogenase or a whole-cell system.  By using BVMOs from different sources and various structurally different ketones as non-native substrates, high stereoselectivity has been observed numerous times.18-24 Moreover, directed evolution25-30 has been applied to influence the chirality of the reaction products, but the targeted enzyme, cyclohexanone monooxygenase from Acinetobacter calcoaceticus NCIMB 9871 (AcCHMO),31-36 is highly unstable and rather unsuitable for application. The first example of BVMO directed evolution involved the stereoselective desymmetrization of 4-hydroxycyclohexanone, catalyzed by AcCHMO.31 Later the result was rationalized by QM/MM computations37 using the insights gained by a previous theoretical study concerning the mechanism of the enzyme as catalyst in the desymmetrization of 4-methylcyclohexanone.38  The control of regioselectivity in the reaction, leading to two constitutionally isomeric products (Scheme 1) continues to be a central synthetic and mechanistic issue.1-4 Stereoelectronic effects governing the reaction outcome2-4 have been addressed in a number of QM computational and mechanistic studies.39-42 In the generally accepted model, the Criegee intermediate is found in a conformation in which the migrating group is antiperiplanar to the fragmenting peroxy O–O bond. This so-called primary stereoelectronic effect enables the preferred reaction due to an optimal overlap of the C–R ơ-bond with the O–O ơ*-orbital. As the O–O is broken heterolytically, the best migrating groups are those that stabilize the partial positive charge best and were experimentally determined to follow the tendency tert-Bu > Phe ~ Iso-Pr > Et 
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 Scheme 1. Baeyer-Villiger reaction of asymmetrical ketones with potential formation of two different esters. Biocatalytic BV oxidations likewise adhere to the stereoelectronic effects which govern the migratory aptitude, but the protein environment in the binding pockets of these enzymes may lead to the formation of abnormal products or mixtures, depending on the enzyme. Previous protein engineering work included the switch from abnormal to normal product in the BV reaction of (+)-trans-dihydrocarvone catalyzed by an evolved CHMO mutant from Arthrobacter sp.43 A unique case of a non-biased ketone concerns the reaction of 2-butanone, which several CHMOs convert to a 3:1 mixture of normal and abnormal product.44 A semi-rational mutagenesis strategy applied to AcCHMO induced a moderate shift from 26% (WT) to 40% (mutant I491A) abnormal product.33 In the present study, we addressed the two challenging problems of switching BVMO stereo- and regioselectivity. The plan was to introduce effective point mutations by directed evolution, flanked by a theoretical study in the quest to unveil the structural and mechanistic reasons for these switches. We used the recently discovered CHMO from Thermocrispum municipale DSM 44069 (TmCHMO). This enzyme is characterized by good thermostability, and has been shown to accept ketones such as cyclohexanone, acetophenone, phenylacetone and 2-octanone, but stereo- and regioselectivity have not been studied to date. Experimentally, we applied our previously developed semi-rational directed evolution technique based on Combinatorial Active-Site Saturation Test (CAST) and Iterative Saturation Mutagenesis (ISM) at sites lining the binding pocket,30,45 flanked by protein QM/MM computations.46-47 
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1a 2a 3aScheme 2. Baeyer-Villiger oxidation of 4-methylcyclohexanone (1a) catalyzed by TmCHMO. We then set out to invert stereoselectivity by protein engineering. Lactone R-2a is a chiral compound of particular interest because it is a precursor of R-β-methyl-substituted adipic acid, which in turn is an important intermediate in the synthesis of an effective inhibitor of acetylcholinesterase (AChE)49 as shown in Scheme 3. In earlier work, a mutant of cyclopentanone monooxygenase from Comamonas sp. was shown to be R-selective (96% ee) in this reaction,50 but this BVMO, as AcCHMO, lacks sufficient thermostability and robustness under operating conditions to be of practical significance. A PAMO variant was also shown to be R-selective (98% ee), but activity proved to be poor.51 
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Subsequently, 11 amino acids within 5 Å from the docked substrate were chosen for saturation mutagenesis (L145,L146, F248, F279, R329, F434, T435, N436, L437, 492, and F507) (Figure 1). These positions were subjected individually to NNK-based randomization in which all 20 canonical amino acids are used as building blocks, requiring in each case the screening of about 96 transformants for 95% library coverage (one microtiter plate).45,52-53 Such exploratory experiments are fast and deliver valuable information for subsequent mutagenesis steps. 
 Figure 1. TmCHMO structural model showing docked 4-methylcyclohexanone (1) (in cyan) based on the crystal structure of wild-type TmCHMO (5M10),48 which served as a guide for choosing amino acids for saturation mutagenesis (in purple). In the mini-libraries generated by saturation mutagenesis at positions 146, 434, 435, 437 and 507, several mutants were discovered showing decreased S-selectivity, namely L146E, F434I, T435F, T435Y, T435W, L437G, L437T, L437A and F507W, thereby pointing the way towards reversal of enantioselectivity. The libraries created at the other six positions failed to harbor any positive variants (Table S9.1). At this stage we explored two mutagenesis strategies in parallel. In one approach, saturation mutagenesis at a relatively large 5-residue randomization site defined by the above hot spots was performed. This time, appropriately reduced amino acid alphabets, individually designed for each of the five residues were used.45,52-53 The respective design was based on the information that the initial positive mutants provided (Table S9.2). Accordingly, 146E/L, 434I/F, 435 F/Y/W/T, 437T/A/G/L and 507W/F, including the amino acid alphabets encoding wild type and positive mutations at individual positions, were chosen for creating a 5-residue saturation 
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mutagenesis library. A total of only 384 transformants were screened for 95% library coverage, and three R-selective variants were indeed identified (Table S9.3) showing moderately reversed enantioselectivity (50%-66% ee). According to the second strategy, the best hit identified in the exploratory NNK-based mini-libraries, mutant L437A, was chosen as a template for performing iterative saturation mutagenesis (ISM) at the remaining four hot spot residues (L146, F434, T435 and F507), which were grouped into two randomization sites: A (F434, T435) and B (L146, F507). Thereafter, several ISM pathways were explored using the respective best variants as templates and NDT codon degeneracy encoding only 12 amino acids (Phe, Leu, Ile, Val, Tyr, His, Asn, Asp, Cys, Arg, Ser, and Gly) (Figure 2). Two excellent R-selective mutants, which could not have been found in the above described 5-residue saturation mutagenesis library, were identified, LGY3-4-E5 (F434I/T435L/L437A/F507V, in the following called E5) (91% ee) and LGY3-4-D11 (L146F/F434I/T435L/L437A/F507C, in the following called D11) (94% ee). All results are summarized in Figure 2 and Table S9.4. In this ISM strategy, a total of only 768 transformants had to be screened for 95% library coverage. This is more than the first approach in which the 5-residue site was randomized by a single saturation mutagenesis experiment using optimally designed codons at each individual position (384 transformants). However, the screening effort involved only 8 microtiter plates which could easily be handled by automated GC. The superiority of the ISM-based approach has to do with the greater structural diversity at protein level. 
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By measuring the consumption of NADPH in the presence of varying amounts of 4-methylcyclohexanone, the enzyme kinetic parameters were determined using a spectrophotometer (Figure S9.1).48,54 Under the experimental 
conditions (150 µM NADPH, 5% methanol, pH 7.4), the wild type showed an uncoupling rate of 0.22 s-1. The maximum turnover rate kcat was determined to be 1.9 s-1, while the affinity for 4-methylcyclohexanone was so high that a Km 
<1 µM could only be estimated. For the D11 mutant, a Km could not be accurately determined, because the activities with concentrations lower than the apparent Km were almost undistinguishable from the uncoupling rate (0.16 s-1). The Km of the E5 mutant is approximately 5.5 mM and a lowered uncoupling rate in 5% methanol of 0.05 s-1 was observed. The kcat was determined to be 8 times lower than wild type for the D11 mutant, while the E5 mutant was close to wild type with 1.23 s-1. It is striking to see that all four mutants that show a high enantioselectivity (Figure 2) have a mutation of F507 in common, while L146 is only mutated in two of these mutants. This suggests that the F507 mutations play a dominant role in equipping the enzyme with high enantioselectivity for the target substrate while the L146 mutations may only have a marginal effect and may even harm the kinetic performance as observed in the D11 mutant. Some degree of substrate inhibition, which is not unusual for BVMOs,22-24,55 was observed in all cases. The wild type is half-maximal inhibited at a concentration of 13 mM. In the E5 mutant, inhibition is less strong, with a Ki roughly 3 times higher than that of wild type. The fitting for the D11 mutant suggests a 20 times higher Ki than wild type, but has to be considered unreliable for the same reasons as the Km determination (Table 1, Figure S9.1). The melting temperatures (Tm) of wild type and both mutants were determined with a fluorescence-based thermal shift assay (ThermoFAD).56 The results indicate that the thermostability of the mutants is not negatively affected, as the Tm was found to be slightly higher than WT TmCHMO (Table 1). Table 1. Kinetic and thermostability data of WT TmCHMO, and mutants D11 and E5. 4-Methylcyclohexanone (1a) was used as substrate for the kinetic analysis.  Entry Mutations kcat (s-1) Km (mM) Ki (mM) kunc (s-1) Tm (°C)b WT  1.93 ± 0.03 <0.001 13 ± 3 0.22 ± 0.08 49.8 LGY3-4-D11 L146F/F434I/T435L/ L437A/F507C 0.2 n.d.a n.d.a 0.16 ± 0.01 53.0 LGY3-4-E5 F434I/T435L/L437A/ F507V 1.23 ± 0.09 5.5 ± 0.8 47 ± 8 0.05 ± 0.00 51.5 a n.d. = not determined, due to unreliable fitting only a maximal observed rate is given. All experiments were done in triplicates.  b the standard deviation (triplicates) was < 0.5 °C. 
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We also compared the two best mutants as catalysts for a panel of cyclic substrates (1-15, Scheme S9.1), and found no predictable consistency with respect to selectivity changes (Table S9.5). The mutations had little influence on other substituted cyclohexanones, regardless of position and nature of the substituent. We found inversion of enantioselectivity from S to R in the mutants’ conversion of 3-(4-chlorophenyl)cyclobutan-1-one, while they were highly R selective for the unchlorinated substrate. The results suggest that the largely unpredictable outcome of the wild type’s enantioselectivity holds also true for the mutants.  Investigation of the Origin of Enantioselectivity by Computational Modeling.  In an attempt to unravel the origin of the enantioselectivity switch for 1, a computational analysis on TmCHMO wild type (WT) and the D11 and E5 mutants with 4-methylcyclohexanone was performed. Energy minimizations determined the ligand in the chair conformation and with the methyl group equatorial as the conformation of lowest energy. The substrate was then docked into the active site of the WT and the mutants. The active side chain residues were kept flexible, while the rest of the protein was fixed. The docking pose with the carbonyl carbon (Cyl) close (< 3.41 Å) to the distal oxygen of the peroxygen group (Oper) with the highest binding energy was accepted as the final docking pose and all are shown in Figure 3. The best docking result in the WT matches the previously described pose in the closely related CHMO from Rhodococcus sp.38 Both the oxo- as well as the methyl group of the substrate point “up” (with respect to the orientation in Figure 3), in an angle pointing away from the flavin’s isoalloxazine ring plane. In contrast, in the mutants, the molecule is rotated around the carbonyl bond axis (Figure 4), such that the methyl is pointing towards the flavin plane. While in the D11 mutant, the rotation approximates 180° and the carbonyl group overlaps with the WT pose, it is slightly shifted (~ 1.2 Å) in E5 mutant, where it is rotated ~140° with respect to WT.  Due to the chair conformation, the chiral outcome of the reaction is already apparent from the substrate reactant complex before the addition step. The α-carbon close to the view plane in Figure 3 is different in the WT than in the mutants (Figure 4) and this quasi-chirality allows to distinguish the two α-carbons. In the WT, if oxygenation occurs where indicated by a red arrow in Figure 4A, then the S product is afforded. Due to the rotation in the D11 mutant, an oxygen insertion at the same place here leads to the R product.  
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9  Figure 3. Docking poses of 1 in TmCHMO WT and mutants. The top panel shows the substrate in ball and stick representation and the isoalloxazine ring of the flavin as well as the ribose and nicotinamide part of NADP+ as sticks. The bottom panel shows the scene from a 90° rotated perspective and in the context of the secondary structure of the proteins as ribbons, as well as the mutated residues as sticks. 
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Figure 4. Rotation of the substrate in the WT compared to the mutants. A) Orientation in the WT, where the orientation of the methyl away from the isoalloaxine ring plane leads to the S product, if oxygen insertion occurs next to the right-hand side carbon. The exact opposite orientation in the D11 mutant (B) causes the R product upon insertion at the same position. As it is known that in the Criegee intermediate, it is the C–C bond antiperiplanar to the peroxy group that migrates, we looked at the dihedral angles formed by 
the peroxy oxygens, the carbonyl carbon, and the α-carbons. Antiperiplanarity was here defined as the conformation where the angle peroxy O–O and carbonyl C–C is 0°. Figure S9.2 shows that in the WT, the two angles were 99° and 50° and the carbon on the right therefore fulfills the criterion of antiperplanarity more closely, suggesting S product formation upon oxygenation (Figure 4). Contrarily, in the D11 mutant the other angle is smaller, suggesting formation of the R product. In E5, however, although the angles are similar (75° vs. 69°), the pose suggests S product formation. Nevertheless, these measurements represent the reactant state, while really the conformation in the Criegee intermediate determines the bond migration. For the reaction to occur, the critical factors are the distance Cyl–Oper, as well as the angle Oper–Cyl–Oyl. With 3.22 Å, the sum of the van der waals radii of carbon and oxygen57 is close to the 3.41 Å determined in a previous study performing QM calculations on the reactant complex.38 The obtained angle was not reported, but it is known that the nucleophile approaches the carbonyl group ideally at 107°.58 The distances and angles of the three docking poses are summarized in Table 2. While the Cyl was always the closest carbon to Oper and always closer than 3.41 Å, the angle deviated considerably from 107°.  Table 2. Distances of Oper and Cyl and the angle Oper–Cyl–Oyl. Reactant complex Ideal value WT D11 E5 Distance peroxy-carbonyl (Å) < 3.41 Å 2.91 2.88 2.73 Angle peroxy-carbonyl (°) 107° 72.8 81.4 78.4 The docking thus resulted in a complex which is similar to the pose of the substrate in a reacting state. The principle observation is that the mutants seem to stabilize the substrate in a flipped orientation compared to WT.  
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To gain a more thorough understanding of substrate binding, the docking structures were subjected to classical MD simulations. QM charge distribution on the cofactors and the substrate were calculated on HF6-31G* level and five independent simulations of 10 ns were performed for each complex. Figure S9.3 shows the trajectory of these initial MDs plotting the critical distance and angle and the results are summarized in Table 3.  Major shifts in the trajectories were occasionally observed, corresponding to displacements of the substrate (e. g. due to loss of a hydrogen bond), resulted from a conformational change (e.g. from chair to boat), or reflected the rotation of the peroxy group. The latter occurred throughout the entire simulation in the WT, and we consequently measured a sustained high Oper–Cyl distance. Figure 5A exemplarily shows a simulation screenshot of seed 1 of the WT at time 0, and after 25 ps. This immediate rotation away from the substrate is supposed to be an artifact, but was kept throughout the entire 10 ns of simulation (Figure 5B). Although this rotation was also observed in the mutants, a reorientation towards the substrate occurred there.  
Figure 5. A) Reorientation of the peroxy group away from the substrate. B) MD trajectory of the ligand for selected seeds shown as superposition of snapshots recorded every 25 ps. Seed 1 was selected for WT and D11, the E5 trajectory was seed 2. In all cases, the ligand stayed relatively stable. In general, the ligand’s position was relatively stable (Figure 5B), with root mean square fluctuations typically less than 1 Å, and no flips around the carbonyl axis. However, in the D11 mutant, the ligand quickly changed orientation from the “full-flip” rotation with respect to the WT docking pose, to an E5 docking-like orientation. Thus, this seems to be the more stable orientation in both mutants. The WT adopts a slightly rotated position compared to the docking pose, but it cannot be excluded that this is an artifact arising from the rotated peroxy group.  We looked at the development of the distances and angles using two different sets of criteria as cutoff to determine the complex to be reactive (“near attack conformation”, NAC). The geometries did not reflect the experimentally 
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observed preference of the enzymes well, but stricter criteria (smaller distance, angle deviation less tolerant) improved the results.  To next estimate the extent to which our observations were biased by the starting structure, we performed a new docking confined to the previous substrate position and subjected two similar positions with opposite orientations, i.e. with rotated conformations (Figure S9.4), to MDs. The results are summarized in Table 3, and the MD trajectory depicted in Figure 6. We found that the R/S distribution depended strongly on the starting structure, with R/S distributions of around 100%. Table 3. NAC parameters and corresponding NAC percentage and R/S distribution enz-yme criteri-on set starting pose dist-ance must be min. min. angle max. angle % NAC % S % R WT 1 CH3 ↑a 3.41 yes 82 132 0 - - WTD11 1 CH3 ↑a 3.41 yes 82 132 0.91 53.6 46.5 D11 E5 1 CH3 ↑a 3.41 yes 82 132 8.56 40.7 59.4 E5 WT 2 CH3 ↑a 3.22 yes 92 122 0 - - WTD11 2 CH3 ↑a 3.22 yes 92 122 0.04 38.0 62.1 D11 WT 1 CH3 ↑b 3.41 yes 82 132 6.3 0.1 99.9 D11 1 CH3 ↑b 3.41 yes 82 132 3.3 0 100 E5 1 CH3 ↑b 3.41 yes 82 132 0 0 100 WT 1 CH3 ↓b 3.41 yes 82 132 2.3 99.5 0.5 D11 1 CH3 ↓b 3.41 yes 82 132 11.2 100 0 E5 1 CH3 ↓b 3.41 yes 82 132 6.1 99.7 0.3 aData sets from first and from bsecond docking set are indicated.  The trajectories showed that the substrate’s position is stable in the WT when starting with the methyl group up, as in the first docking structure. In the opposite orientation, an orientation flip was observed. Furthermore, no NACs occurred before the flip, while they did occur in the apparently preferred flipped rotation. In the D11 mutant, both orientations led to NACs, but an unproductive sideward conformation could be visited when starting with the methyl group up. In the E5 mutant, the position with the methyl group up prevents NACs, while the opposite orientation causes NACs until a flip occurs. In contrast to the WT, however, no NACs occur after the flip. These results are in line with the docking, showing that the preferred pose for the WT is with the methyl group up, to an extent that the switch can be observed when deliberately starting MDs in the opposite orientation. The D11 mutant seems to cope with both positions, but docking suggests the methyl down position to be energetically favored. The E5 mutant can also flip from its “preferred” position, but this prevents NACs. In general, the results show that the observed R/S selectivities strongly depend on the starting structure.  
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Figure 6. Selected seeds of the second docking pose MD simulations (Figure S9.4, A: methyl up, B: methyl down), their R/S selectivity over time, and the corresponding snapshots superposed. The Cyl–Oper distance (upper line), and the Oper–Cyl–Oyl angle (lower line) are plotted against time. When Cyl was the closest carbon to Oper, closer than 3.41 Å, and the angle between 92° and 122° (107° ± 25°), the pose was considered a “near attack conformation. In this case, the dihedral angle peroxy O–O and carbonyl C–C is depicted as a golden or grey bar when favoring the S or R product, respectively. To better visualize the orientation of the methyl group, the hydrogen at C4 is shown, which points in the opposite direction of the methyl carbon.  As we again frequently observed the peroxy group in a non-productive pose, we repeated the MDs with a restraint on these atoms. Figure 7 shows the results for the two different starting structures, comparing five criteria sets. When starting from the methyl down (the “mutant”) position, the results came close to reflect experimental results, with the WT fully S, and the mutants predominantly R-selective (Figure 7, top). When starting with the methyl up (the “WT”) position, the mutants selectivity was mostly inversed (Figure 7, bottom). 
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Figure 7. NAC percentages (dots) and R/S preference (grey/white bars) for MD simulations with a restrain on the peroxy group, compared for five sets of parameters. A) starting position with the methyl group upwards. B) Starting position with the methyl group downwards. These results were also found to be robust, as they were relatively insensitive to the NAC parameters chosen (Table 4). Only for D11, where the NAC frequency was very low, a change in parameters had a more noticeable effect.  Table 4. Parameter sets for Figure 5. crit. set distance has to be min. min. angle max. angle max. angle peroxy 1 3.41 yes 82 132 360 2 3.22 yes 92 122 360 3 3.22 yes 77 137 30 4 3.22 no 62 152 45 5 3.41 no 0 360 360 In summary, the computational analysis provided clues on the origin of selectivities. The docking suggested distinct poses for the mutants, inversed to the position in the WT, and MD simulations demonstrated the stability of these two positions. When we deliberately started MDs with both orientations in either variant it was found that the supposedly unpreferred position of the WT switched to the preferred position and only there the pose was reactive. In D11, the substrate seemed to be stable in both positions, while a switch occurred also in E5, here leaving its supposed preferred position to an unproductive pose. R/S selectivities were found to be difficult to estimate from reactant states: the docking pose did not reveal the preferred bond migration from the 
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 Scheme 4. Baeyer-Villiger oxidation of regioselectivity model ketones 17, 20 and 23 catalyzed by TmCHMO. In the case of ketone 17, L145A, L145G, L145V, L437T and L437A showed decreased selectivity for the normal product 18, thus pointing the way towards regioselectivity reversal. The best, L145G, was chosen as a template to visit 
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position L437, leading to two variants with reversed regioselectivity, LGY2-B12 (L145G/L437T, 18:19 = 17:83) and LGY2-D8 (L145G/L437V, 18:19 = 23:77). Thereafter, LGY2-B12 (L145G/L437T) was used as a template to test ISM by considering the remaining 9 residues (L146, F248, F279, R329, F434, T435, N436, W492 and F507), which were grouped into five randomization sites: A (F279, F507), B (L146, N436), C (F248, W492), D (F434, T435) and E (R329). In contrast to our earlier stereoselectivity study, this meant that residues were considered that were not hotspots in the initial 11 exploratory NNK-based mutagenesis experiments. In order to minimize the screening effort, NDT codon degeneracy encoding only 12 amino acids (Phe, Leu, Ile, Val, Tyr, His, Asn, Asp, Cys, Arg, Ser and Gly) were chosen for constructing libraries at the 2-residue sites (A, B, C and D). This required in each case the screening of 4 microtiter plates for 95% coverage assuming the absence of bias, and for the NNK single amino acid library E one plate only. Several mutants were discovered showing significantly enhanced regioselectivity favoring the abnormal product 19 in library D, namely LGY3-D-A9 (L145G/F434I/T435I/L437T, 18:19 = 3:97), LGY3-D-E1 (L145G/F434G/T435F/L437T, 18:19 = 2:98), LGY3-D-B7 (L145G/F434N/T435G/L437T, 2:3 = 8:92), and LGY3-D-E9 (L145G/F434G/T435Y/L437T, 18:19 = 7:93). The libraries created at the other four sites did not harbor any positive variants (Table S9.6). The best results are summarized in Figure 8A. An analogous procedure was applied to ketone 20, the best results being summarized in Figure 8B (see also Table S9.7 for full details). As can be seen, regioselectivity favoring the abnormal product 22 was achieved starting from an initial complete preference by wild-type TmCHMO for the normal product 21 formed by benzyl migration, but the degree of reversal remained at the incomplete stage of 21:22 = 30:70. Nevertheless, in view of the BV reaction using m-CPBA which occurs with exclusive benzyl migration, this is a synthetically remarkable result. 
Figure 8. Iterative saturation mutagenesis (ISM) exploration of TmCHMO as catalyst in the reactions with focus on reversal of regioselectivity in favor of the abnormal product using substrate 17 (A), 20 (B), or 23 (C). 
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In the case of ketone 23, WT TmCHMO proved to be selective for the normal product 24 produced by preferential 2-phenylethyl migration, but a small amount of the abnormal product 25 was also formed (24:25 = 85:15). Upon screening the 11 mini-NNK libraries (Figure 8C and Table S9.8), it was possible to improve the initial outcome to nearly exclusive preference for the normal ester (24:25 = 98:2), and also to completely reverse regioselectivity in favor of the abnormal product (24:25 = 3:97). Surprisingly, it required less steps to evolve mutants that allow either benzyl migration or ethyl migration on an optional basis, in contrast to the outcome of the reaction of ketone 20 in which benzyl competes with the smaller methyl group. Table 5. Kinetic parameters of WT TmCHMO and best mutants evolved for the abnormal BV product of three substrates. Enzyme Substrate Mutations kunc (s-1) Km (mM) kcat (s-1) Tm (°C) WT 17 - 0.02 ±  0.00 12 ± 7.0 0.31 ± 0.11 52.67 ± 0.76 LGY3-D-A9 17 L145G/F434I/ T435I/L437T 0.20 ±  0.02 n.d. n.d. 50.83 ± 0.76 LGY3-D-E1 17 L145G/F434G/ T435F/L437T 0.10 ± 0.01 0.02 ± 0.00 0.16 ± 0.00 51.33 ±  0.76 WT 20 - 0.07 ±  0.03 0.90 ± 0.06 0.73 ± 0.01 52.67 ± 0.76 LGY2-B6 20 L437A/W492Y 0.07 ±  0.01 1.50 ± 0.46 0.16 ± 0.01 55.33 ± 0.29 WT 23 - 0.02 ±  0.00 4.40 ± 1.00 0.37 ± 0.03 52.67 ± 0.76 LGY1-492-A7 23 W492Y 0.03 ± 0.02 5.50 ± 1.70 0.18 ± 0.03 53.50 ± 0.50 LGY1-248-D3 23 F248D 0.03 ± 0.00 0.02 ± 0.02 0.07 ± 0.01 47.83 ± 2.02 LGY1-437-E12 23 L437A 0.01 ± 0.00 2.80 ± 0.36 0.36 ±  0.02 55.33 ±  0.29 Due to the possibility of ester hydrolysis catalyzed by endogenous lipases or esterases in E. coli cells, the BV oxidations of the three substrates 17, 20 and 23 were repeated using purified enzyme of the best TmCHMO mutants. The results turned out to be the same (Table S9.9), or even slightly better, e.g., LGY3-D-E1 (18:19 = 2:98), LGY2-B6 (21:22 = 26:74), and LGY1-248-D3 (24:25 = 99:1). A previous report also noticed a possible effect of substrate concentration on the regioselectiviy,59 thus we also tested the WT and the mutant LGY3-D-E1 in the conversion of 17 at 50 mM and 100 mM concentrations. In our system, all reactions retained a high regioselectivity as shown Table S9.10, WT leading to 18:19 > 99:1 and LGY3-D-E1 leading to 18:19 < 3:97. 
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We next determined the kinetic parameters for the wild type enzyme and the most promising mutants with the corresponding substrates as shown in Table 5 and Figure S9.5. Using purified enzymes, we spectrophotometrically measured the rate of oxidation of the NADPH cofactor at varying substrate concentrations. The uncoupling rate kunc, i.e. the unproductive decay of the peroxyflavin without substrate oxidation, was measured in control reactions without substrate. It was found to be very low for the WT and most mutant enzymes (0.02-0.10 s-1) except for mutant LGY3-D-A9 (0.20 s-1), prohibiting accurate determination of its kcat and Km values for 17. For the WT enzyme, 20 was found to be the best of the three substrates, with a kcat of 0.73 s-1 and a Km of 0.86 mM. The evolved mutant LGY2-B6 showed a reduced kcat of 0.16 s-1, and with a Km of 1.5 mM also a somewhat lower affinity for the substrate than WT TmCHMO. On the other hand, mutant LGY3-D-E1 illustrated a drastically increased affinity to substrate 17 as compared to WT (kcat = 0.31 s-1, Km = 12 mM versus kcat = 0.16 s-1, Km = 0.02 mM). For substrate 23, the mutant LGY1-492-A7 displayed similar kinetic parameters relative to WT. LGY1-248-D3 hada very low Km (0.02 mM), but also obviously decreased kcat and probably suffers from substrate inhibition. Clearly the best mutant is LGY1-437-E12, showing aslightly lower Km than WT but the same kcat.To probe thermostability, we measured the melting temperatures (Tm) of WTand all the evolved mutants, using the ThermoFAD method.56 It was found thatthe thermostability of most mutants is maintained as compared to WTTmCHMO, except for LGY1-248-D3 showing a 5 °C drop in Tm (Table 5).We also tested the best mutant LGY3-D-E1 for semi-preparative scaledtransformation of substrate 17 (50 mg) in 25 mL of reaction volume. Fullconversion was achieved within 24 h, while maintaining the originally evolvedhigh regioselectivity as analyzed by GC. After purification using columnchromatography, 46 mg product 19 (83% isolated yield), identified by NMR,was obtained (Figures S9.6, S9.7).Unraveling the origin of regioselectivity by computational modeling To gain more insights into the regioselectivity switch through directed evolution, we computationally modeled the reaction. In the light of the experience from the enantioselectivity mutants, we now used DFT computations to model the intrinsic reaction preferences and used QM/MM and MD simulations to model the reactions. First, the energy barriers of the rate- and regioselectivity-determining39,60 migration step with m-CPBA were calculated by DFT. The optimized transition states (TSs) showed a clear trend toward the normal product, arising from the better stabilization of the partial positive charge on the migrating carbon atom. In accordance with 
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experimental ratios, the energy differences ΔΔG were computed to be −3.3, 
−5.2, and −1.9 kcal·mol-1 for substrate 17, 20, and 23, respectively (FigureS9.8).In the Criegee intermediate, two conformations are possible, where either ofthe two migrating groups is placed antiperiplanar to the peroxyl O–O bond. We hypothesized that the enzymes may allow only one of the two possible TSs byimposing conformational restrictions. We chose ketone 17 for ourcomputational modeling because it experimentally exhibits the largest degreeof selectivity (Figure 8A). We ran 500 ns MD simulations on the Criegeeintermediate bound into the different enzyme variants and monitored thedihedral angles formed by the peroxy O–O and carbonyl C–C atoms. Here, theantiperiplanar dihedral angle required for migration was defined as ±180°.
Figure 9. Analysis of 17-R-Criegee intermediate conformations though 500 ns MD simulations when bound in the A) WT enzyme; and B) LGY3-D-E1 variant. Black symbols denote selected snapshots used for further analysis in Figure S9.13. In the Criegee intermediate, a new quaternary carbon center is generated. Based on docking results and MD simulations (see Figure S9.9), we concluded that only the R-Criegee stereoisomer may be formed. This conformation keeps a less strained conformation of the phenylethyl group and allows the H-bonding interaction with R329 needed for stabilizing the negative charge generated on the former carbonyl oxygen. In the MD simulations, the intermediate mainly explores a conformation in which the dihedral angle for 
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phenylethyl group migration (dihed1-normal) is ca. 150–180° and the dihedral angle for methyl migration (dihed1-abnormal) is ca. −60 to −100° (Figure 9A). Thus, the enzyme active site only allows the phenylethyl group to adopt the antiperiplanar orientation required for migration. As this group is also most effective in stabilizing the positive charge at the peroxy O-atom in the transition state, these results are fully consistent with the exclusive formation of the normal BV product 2 by the WT (Figure 8A).  When we measured the LGY3-D-E1 variant, the dihedral angles for the phenylethyl migration (dihed1-normal) and methyl migration (dihed1-abnormal) indicated that two interconverting conformations of the Criegee intermediate can be explored (Figure 9B). From these results, one may expect to observe the formation of both possible BV products, in contrast to experimental results. We selected two snapshots from the MD trajectory of LGY3-D-E1 where the two different bound conformations are visited (Figures 9B, S9.10) and carried out QM/MM calculations. The QM/MM calculated energy barriers are 17.5 kcal·mol-1 for the methyl migration TS (17-TS-abnormal, snapshot at 300ns) and 20.8 kcal·mol-1 for the phenylethyl migration TS (17-TS-normal, snapshot at 100ns). Thus, although a conformation of the Criegee intermediate leading to the normal BV product 18 can be visited, the high energy 17-TS-normal prevents this pathway and favors the abnormal product 19 through a much lower energy 17-TS-abnormal. The consequence is preferred methyl migration, even though this group is least effective in stabilizing the incipient positive charge in the transition state (Scheme 2).  In order to understand the origins of the high energy barrier for the normal product formation in the LGY3-D-E1 variant, we analyzed the phenylethyl migration TS in the WT (Figure S9.10D). In this case, the QM/MM computed energy barrier is with only 14.3 kcal·mol-1 more than 5 kcal·mol-1 lower. This likely results from a more distorted phenylethyl migrating group in LGY3-D-E1 due to the new conformation of the Criegee intermediate. The LGY3-D-E1 17-TS-normal is a late TS as compared to the WT 17-TS-normal and the LGY3-D-E1 17-TS-abnormal (Figure S9.10D-F), where the main differences arise from the breaking C–C bond distances (1.93 Å vs. 1.77 Å and 1.76 Å, respectively).  As shown in Figure S9.10A−C, the L145G and L437T mutations create more space to accommodate the phenyl ring. At the same time, L437T is H-bonding and displacing the FAD cofactor, and stabilizing the Criegee intermediate through CH-π interactions with the phenyl ring. Finally, the F434G and T435F mutations allow W492 to move closer to the Criegee intermediate phenyl, pushing and forcing it to keep that particular orientation. These effects increase the strain on the phenylethyl group when migrating, resulting in a 
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worse orbital overlap and a destabilization of this normal migration TS. Contrarily, the new conformation explored by the Criegee intermediate allows the abnormal methyl migration. Consequently, the mutations enable LGY3-D-E1 to stabilize a bound conformation and a TS that efficiently leads to the abnormal product. Moreover, the intrinsically preferred migration pathway is destabilized by increasing the barrier of the normal migration TS due to cooperative effects of the mutated residues.  Conclusions In summary, we have addressed the challenging issues of reversing the stereo- and regioselectivity of a Baeyer-Villiger monooxygenase. This was accomplished by applying iterative saturation mutagenesis (ISM) at sites lining the binding pocket of the thermally stable TmCHMO. Two mutants emerged that are excellent biocatalysts for the asymmetric transformation of 4-methylcyclohexanone and other structurally diverse ketones. In some cases the high enantioselectivity in desymmetrization reactions is similar to those reported for the prototype AcCHMO. However, this well-known BVMO is only moderately stable in contrast to the robust TmCHMO used here and this stability was retained in the mutants. The reversal of enantioselectivity as reported herein allows ready access to several chiral compounds of particular synthetic value. A computational analysis gave hints on the origin of the selectivity switch and suggested a flipped substrate binding mode in the mutant as compared to the wild type. MD simulations revealed limitations when analyzing reactant states and suggested electronic effects in the intermediate could play a role in selectivity. We also developed mutants for switching the regioselectivity in reactions of three structurally unbiased linear ketones. The switch involves the preferred formation of the abnormal product resulting from selective group migrations in the respective Criegee intermediates, which are normally disfavored due to stereoelectronic effects. The results are of synthetic significance because the standard reagent for Baeyer-Villiger oxidations, m-CPBA, was shown to provide the normal products in all three cases. The evolved mutants suffered essentially no tradeoff in thermostability and activity as shown by Tm measurements and kinetics, respectively. In terms of mutagenic “hot spots” in TmCHMO, our study reveals, inter alia, that position L437 plays an especially critical role in controlling the regioselectivity in reactions of two of the three model ketones, but other positions are also of distinct importance. In future protein engineering efforts, simply combining some of the known mutations may prove to be a simple and fast way to obtain selective BVMOs with little or 
Engineering the Selectivity of BVMOs 
210 
  9 
no high-throughput screening, provided the respective “rational” choices are guided by structural and theoretical information.  A model for explaining the molecular phenomenon behind the reversal of regioselectivity was constructed by MD simulations and QM/MM computations. The mutations induce conformational changes of the respective Criegee intermediates in the enzyme’s binding pocket, which allow the abnormal TS while largely destabilizing the normal migration TS. This novel conformational control leads to the violation of the traditional rule that those migrating groups are preferred that stabilize the incipient positive charge at the peroxy O atom in the Criegee intermediate most effectively. The steric effects that we observed overcame otherwise favorable stereoelectronic effects. Such a novel mechanism of control adds another way that enzymes can control selectivity, and complements the electrostatic factors shown to control competing pathways in terpene cyclases.61 We hope that the mechanistic lessons learned and the insights gained from our theoretical study will provide a basis for making future protein engineering of BVMOs easier and faster. Materials and methods Materials KOD Hot Start DNA Polymerase was obtained from Novagen. Restriction enzyme DpnI was bought from NEB. The oligonucleotides were synthesized by Life Technologies. Plasmid preparation kit was ordered from Zymo Research, and PCR purification kit was bought from QIAGEN. DNA sequencing was conducted by GATC Biotech. All commercial chemicals were purchased from Sigma-Aldrich, Tokyo Chemical Industry (TCI) or Alfa Aesar.  PCR based methods for library construction of TmCHMO Libraries were constructed using Over-lap PCR and megaprimer approach with KOD 
Hot Start polymerase. 50 µL reaction mixtures typically contained 30 µL water, 5 µL 
KOD hot start polymerase buffer (10×), 3 µL 25 mM MgSO4, 5 µL 2 mM dNTPs, 2.5 µL 
DMSO, 0.5 µL (50~100 ng) template DNA, 100 µM primers Mix (0.5 µL each) and 0.5 
µL KOD hot start polymerase. The PCR conditions for short fragment: 95 °C 3 min, (95 °C 30 sec, 56 °C 30 sec, 68 °C 40 sec) × 30 cycles, 68 °C 120 sec. For mega-PCR: 95 °C 3 min, (95 °C 30 sec, 60 °C 30 sec, 68 °C 6 min) × 28 cycles, 68 °C 10 min. The PCR products were analyzed on agarose gel by electrophoresis and purified using a Qiagen 
PCR purification kit. 2 µL NEB CutSmart™ Buffer and 2 µL Dpn I were added in 50 µL PCR reaction mixture and the digestion was carried out at 37 °C for 7 h. After Dpn I 
digestion, the PCR products 1.5 µL were directly transformed into electro-competent E. coli Top10 to create the final library for Quick Quality Control (QQC)3 and screening. 
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Primer design and library creation of TmCHMO Primer design and library construction depend upon the particular amino acid chosen, and the eleven single sites saturation mutagenesis libraries (L145，L146，F248， F279，R329， F434，T435， N436， L437，W492 and F507) of TmCHMO were constructed following the following procedure:  Enantioselectivity libraries 1) Amplification of the short fragments of TmCHMO using mixed primers L145NNK-F/L145-R, L146NNK-F/L146-R, F248NNK-F/F248-R, F279NNK-F/F279-R, R329NNK-F/R329-R, F434NNK-F/F434-R, T435NNK-F/T435-R, N436NNK-F/N436-R, L437NNK-F/L437-R, W492NNK-F/W492-R and F507NNK-F/F507-R for libraries L145NNK, L146NNK, F248NNK, F279NNK, R329NNK, F434NNK, T435NNK, N436NNK, L437NNK, W492NNK, and F507NNK, respectively; 2) Amplification of the whole plasmid TmCHMO using the PCR products of step1 as megaprimers, leading to the final various plasmids for library generation. For rational designed 5-residue randomization mutagenesis library: 1) Amplification of the short fragments of TmCHMO using mixed primers 146E/L-F/434I/F+435F/Y/W/T+437T/A/G/L-R and 434I/F+435F/Y/W/T+437T/A/G/L-F/507W/F-R, respectively; 2) Overlap PCR using the PCR products of step 2 as template and mixed primers 146E/L-F/507W/F-R; 3) Amplification of the whole plasmid TmCHMO using the PCR products of step2 as megaprimers, leading to the final variety plasmids for library generation.  For ISM, the libraries A and B were constructed as following procedure: 1) Amplification of the short fragments of TmCHMO using mixed primers F434NDT/T435NDT-F/F434/T435-R and L146NDT-F/F507NDT-R for Libraries A and B, respectively; 2) Amplification of the whole plasmid TmCHMO using the PCR products of step 1 as megaprimers, leading to the final plasmids for library generation. The PCR products were digested by Dpn I and transformed into electro-competent E. coli Top10 to create the library for screening.  Regioselectivity libraries 1) Amplification of the short fragments of TmCHMO using mixed primers L437NNK-F/L437-R; 2) Amplification of the whole plasmid of TmCHMO using the PCR products of step1 as megaprimers, leading to the final various plasmids for library generation; 3) The PCR products were digested by DpnI and transformed into electro-competent E. coli Top10 to create the library for screening. Other libraries created in the ISM process also followed the same procedure.  Screening procedures Colonies were picked up and transferred into deep-well plates containing 300 µL LB medium with 50 µg/mL carbenicillin and cultured overnight at 37 °C with shaking. An 
aliquot of 120 µL was transferred to glycerol stock plate and stored at −80 °C. 
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Subsequently, 800 µL TB medium containing 0.02% (0.2 g/L) L-arabinose and 50 µg/mL carbenicillin was added directly to the culture plate, then continued to culture it for 16 h at 25 °C with shaking for protein expression. The cell pellets were 
harvested, then washed with 400µL of 50 mM, pH 7.4 potassium phosphate buffer. The 
cell pellets were resuspended in 400 µL of the same buffer and substrate (final 
concentration 10 mM in reaction system) in 20 µl methanol was added. The plates were incubated at 30 °C, 800 rpm, 18 h. The product and remaining substrate were extracted using equal volumes of ethyl acetate (EtOAc) for GC analysis by chiral column (Supplementary Tables S9.11 and S9.12). Protein expression and purification All enzymes were expressed using E. coli Top10 cells in the presence of L-arabinose and purified using Ni-sepharose resin, as previously described.34 The purified HisTag-SUMO-TmCHMO fusion protein was incubated overnight with SUMO protease. Subsequently, a Ni2+-Sepharose column was used to capture the SUMO-His-Tag protein yielding isolated TmCHMO in the flow through. Determination of kinetic parameters Enzyme activity for kinetic parameters was measured by monitoring the consumption of NADPH at 340 nm. The activity assay was performed in a mixture containing 0.15 mM NADPH and varying concentration of 4-methylcyclohexanone (0-50 mM) with 5% (final) methanol as cosolvent. It should be noted that 0.05 µM WT (reacting too fast in 
higher concentration) and 2 µM mutants were used in each reaction. To determine NADPH affinity, varying amounts of NADPH were added to mixture with constant 2.5 mM substrate. The limitations of the assay are the quick consumption of the NADPH at low concentrations and too high absorbance in high concentrations. As we found a relatively high uncoupling rate when using methanol as a cosolvent and the kinetic parameters for the substrates used in the regioselectivity switch are notably slower, we adapted the buffer conditions to minimize uncoupling, and thus preventing a masking of the coupled reaction at low substrate concentrations. In the optimized conditions, the uncoupling rate is 0.02-0.07 s-1, while in the previous conditions (50 mM PBS buffer, 5% methanol as cosolvent), the uncoupling rate of the WT was 0.22 s-1. This would have made an analysis of most of the regioselectivity mutants impossible, since the observed rates were below this value. Kinetics were determined at 25 °C in 100 mM PBS pH 7.4, in the presence of 5% (substrate 4) or 8% (substrates 1 and 7) acetonitrile. Reactions were performed with varying amounts of substrate as shown in Figure S9.5. The final reaction volume was 
200 µL, and NADPH was added to a final concentration of 150 µM as the last component to start the reaction. Initial rates of NADPH oxidation were measured spectrophotometrically (Jasco V-660) following the absorbance at 340 nm for 45 s. The observed rates were plotted against substrate concentration and fitted to the Michaelis-Menten equation to determine the kinetic parameters (GraphPad Prism 6). 
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Determination of thermostability by ThermoFAD method The Tm was determined using the ThermoFAD method. Specifically, 25 µl samples containing 1 mg/mL purified enzyme were prepared in a 96-well thin wall PCR plate, and then the plate was heated from 20 °C to 90 °C, increasing temperature by 0.5 °C/10 seconds, using an RT-PCR machine (CFX96-Touch, Bio-Rad Laboratories), which could measure fluorescence using a 450–490 nm excitation filter and a 515–530 nm emission filter. The melting point was defined as the temperature when the first derivative of the observed fluorescent signal showed maximum value.  Biotransformation reactions for tested substrates 1 mL PBS buffer (pH 7.4, 50 mM) containing recombinant expressed cells (OD600=35) and 10 mM substrate [final concentration, methanol as cosolvent (5% of total volume)] were added into 25 mL flask (providing enough oxygen), and the reaction was performed at 30 °C shaking (220 rpm) for 24 h. The product was extracted with ethyl acetate containing 0.1 mM methylbenzoate as internal standard for GC analysis. Chemical reference reactions Chemical reactions were conducted for the substrates 2-benzylcyclohexanone, 4-phenylcyclohexanone, 4-tertbutylcyclohexanone and bicyclo[4.2.0]octan-7-one, whose enantiomers we could not find through their enzymatic reference reactions. 
Specifically, substrate (4.0 µmol, 8 µl of a 0.5 M stock solution in dioxane) and 3-
chloroperbenzoic acid [8.9 µmol, 20 µl of a 10%w/v stock solution of reagent grade 3-chloroperbenzoic acid (77% w/w) in dichloromethane, 2.2 equiv] were combined in a micro-inlay for GC vials. This results in a final concentration of 0.160 M ketone and 0.360 M peracid. The clear colorless solution was shaken at room temperature for 18 
h. The solution was diluted with dichloromethane (100 µl) and transferred into a 1.5 mL Eppendorf tube. A solution of triethylamine (ca. 45 µmol, 1000 µl of 0.6% v/v solution in dichloromethane, ca. 9 equiv.) and water (500 µl). The biphasic mixture was shaken for 30 min and centrifuged for 30 s at 10 kRCF at room temperature. The aqueous layer was removed and the organic phase was dried over Na2SO4. Methylbenzoat as standard was added and the solution was analyzed via GC. Chemical synthesis of 5-methyloxepan-2-one Synthesis of 5-methyloxepan-2-one: To a solution of 4-methylcyclohexanone (200 mg, 1.78 mmol) in 10 mL CH2Cl2 m-CPBA (800 mg, 4.64 mmol) and TFA (136 µL, 1.78 mmol) was added at 0 °C. The reaction mix was allowed to reach room temperature and left to react 24 h. Next, 10% Na2S2O3 (5 mL) was added and the mixture was further stirred for another 2 h. The organic layer was extracted with CH2Cl2 (3 x 20 mL), washed twice with saturated sol. NaHCO3, and dried over anhydrous MgSO4. The solvent was removed under vacuum, and the crude reaction mixture was purified using 
column chromatography (EA : PE=1:4) to afford 5-methyloxepan-2-one a colorless oil (175 mg, 77%). NMR spectra were in concordance with literature data.62  
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Baeyer-Villiger oxidation of 1, 4 and 7 catalyzed by purified WT TmCHMO and best mutants in analytical level (10 mM) 1 mL PBS buffer (pH 7.4, 50 mM) containing 2 mg purified enzyme, 10 mM substrate [final concentration, methanol as cosolvent (5% of total volume)], 100 µM NADP+, 30 U glucose dehydrogenase and 100 mM glucose were added into 15 mL test tube providing enough oxygen, and the reaction was performed at 30 °C for 15 h shaking. The product and remaining substrate were extracted with ethyl acetate at 1 h and 15 h for GC analysis. Baeyer-Villiger oxidation of 1 catalyzed by WT TmCHMO and variant LGY3-D-E1 in 50 mM and 100 mM. 1 mL PBS buffer (pH 7.4, 50 mM) containing 4 mg purified enzyme, 50 mM or 100 mM substrate 1 [final concentration, methanol as cosolvent (5% of total volume)], 100 µM NADP+, 80 U glucose dehydrogenase and 500 mM glucose were added into 15 mL test tube providing enough oxygen, and the reaction was performed at 30 °C with shaking (220 rpm) for 24 h. The product and remaining substrate were extracted with ethyl acetate for GC analysis. Baeyer-Villiger oxidation of 1 using variant LGY3-D-E1 in semi-preparative scale reaction. 25 mL PBS buffer (pH 7.4, 50 mM) containing 10 mg purified LGY3-D-E1, 50 mg substrate 1 (1 mL methanol as cosolvent), 100 µM NADP+, 200 U glucose dehydrogenase and 200 mM glucose were added into a 250 mL flask providing enough oxygen, and the reaction was performed at 30 °C with shaking (220 rpm) for 24 h. The reaction was stopped by adding ethyl acetate (5 mL). The organic phase was extracted with ethyl acetate (3 x 10 mL), dried over MgSO4 and a sample was collected for the GC analysis. In continuation, the crude reaction product was purified using column chromatography (EA:PE 1:4) to afford 3 as a yellow liquid, (46 mg, yield 83%). 1H NMR 
(300 MHz, Acetone) δ 2.61 (t, J = 7.8 Hz, 2H), 2.91 (t, J = 7.7 Hz, 2H), 3.61 (s, 3H), 7.31–7.15 (m, 5H). 13C NMR (75 MHz, Acetone) δ 31.54 (s), 36.10 (s), 51.59 (s), 126.96 (s), 129.15 (s), 129.25 (s), 141.81 (s), 173.39 (s). Chemistry To perform Baeyer-Villiger oxidation with m-CPBA, a solution of ketone 1, 4 or 7 (1 Eq.) in 5 mL CH2Cl2 was added at 0 °C m-CPBA (2.6 Eq.) and TFA (1 Eq.). The reaction mixture was allowed to reach room temperature and left to react 24 h. In continuation, 10% Na2S2O3 (3 mL) was added and the mixture was further stirred for another 2 h. The organic layer was extracted with CH2Cl2 (3 x 10 mL), washed twice with saturated sol. NaHCO3, and dried over anhydrous MgSO4. The solvent was concentrated under vacuum, and a GC sample from the crude reaction mixture was injected in the GC. 
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Docking 4-methycyclohexanone into WT TmCHMO The X-ray structure of TmCHMO (5M10) was used as the basis for docking calculations. 4-methylcyclohexanone was prepared for docking using ChemDraw. Docking was performed using Autodock Vina and PDB 5M10. Hydrogens were added, and water, buffer and the ligand were removed. To prepare a suitable receptor for ligand docking, a simulation cell was defined by amino acids of the active site cavity (L145, L146, F248, G278, F279, R329, F434, T435, N436, L437, W492, and F507). The docking pose with the carbonyl atom closest to the flavin C4a was taken as the final docking pose.  Computational analysis of the enantioselectivity switch The ligand structure was prepared by building the molecule in its presumed most stable (i.e. least energetic) geometry, that is, with the methyl group in the equatorial position. After enclosing the molecule in an H2O solvent box, an energy minimization was performed, before the final geometry was obtained by using a semi-empirical quantum mechanics algorithm with the COSMO implicit solvent model.63  Next, the enzyme structure was prepared: PDB ID 5M10 was downloaded, alternative side-chain rotamers with higher B-factor were eliminated, hydrogens were added and optimally oriented, and water, buffer and the ligand were removed. Then the peroxyflavin was modeled: a hydrogen was added to the N5, the peroxygroup added to the re side of the flavin at the C4a, and the bond orders updated. The entire structure except the peroxygroup and the C4a was frozen and an energy minimization yielded the out-of-plane C4a, with the distal negatively charged oxygen stabilized above the positive C4, C2 and C10 atoms of the flavin. The mutant structures were prepared by employing a script that swaps the respective amino acids, and subsequently performs a dead end elimination optimization based on rotamers, making use of the SCWRL3 algorithm64 and further optimizes the orientation considering force field and solvation energies.65 The resulting structure was then energy minimized. This approach was repeated in six rounds, with increasing volume of flexible atoms around the mutated site until finally the entire protein is energy minimized.  To prepare a suitable receptor for ligand docking, a simulation cell was defined by enclosing the sidechains of the active site cavity-forming residues:  WT: L145, L146, F248, G278, F279, R329, F434, T435, N436, L437, W492, F507 D11: L145, F146, F248, G278, F279, R329, I434, L435, N436, A437, W492, C507 E5: L145, L146, F248, G278, F279, R329, I434, L435, N436, A437, W492, V507 These atoms were also kept flexible, while the rest of the protein was frozen. The substrate was then docked into the active site using AutoDock 466 with 999 runs and 25m energy evaluations. The results were then visually inspected. The docking pose with the carbonyl atom close (< 3.41 Å) to the distal oxygen of the peroxygen group and the highest binding energy was accepted as the final docking pose. The second docking round was essentially the same, but with the simulation cell confined to the space where the substrate was found to dock in the first round.  Gaussian67 was used to calculate the charge distribution on the peroxyflavin, the NADP+ cofactor, and the substrate. The atom coordinates were kept fixed. ESP charges 
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were calculated using the Hartree-Fock method with Gaussian shaped orbitals of the 6-31* complexity.MD simulations were carried out under YASARA v17.4.17, using either the Yamber3 orthe YASARA forcefield. The procedure was as follows: first a dodecadral simulation cellwith periodic boundaries was defined 7.5 Å around all protein atoms. The cell was filledwith water and then neutralized with sodium and chloride as counter ions. The pH wasset to 7.40 and the protonation states were adjusted accordingly. Then the charges ofthe cofactors were updated to match the charges determined by QM. The MD startedwith an energy minimization experiment, then the temperature was set to 0 K andwithin 30 ps gradually increased to 25 °C. The simulation was allowed to proceed for10 ns. With a new random seed, this procedure was repeated five times, so a total timeof 5 x 10 ns = 50 ns was sampled. A simulation snapshot for later playback was takenevery 25 ps, and every 2 ps, the NAC criteria were recorded.Computational analysis of the regioselectivity switch DFT calculations for modeling m-CPBA BV oxidations were performed using Gaussian 09.67 Geometry optimizations and frequency calculations were performed using unrestricted B3LYP (UB3LYP)68-70 and the 6-31G(d) basis set, within the CPCM polarizable conductor model (dichloromethane).71-72 Enthalpies and entropies were calculated for 1 atm and 298.15 K. Single point energy calculations were performed using the dispersion-corrected functional (U)B3LYP-D3(BJ)73-74 with the 6-311++G(3df,2p) basis set, within the CPCM polarizable conductor model (dichloromethane). All stationary points were verified as minima or first-order saddle points by a vibrational frequency analysis.  QM/MM calculations within the ONIOM approach75-76 were performed using Gaussian 09. 67 Geometry optimizations were performed using unrestricted B3LYP (UB3LYP) in combination with the 6-31G(d) basis set, and using the QuadMac algorithm (asimplemented in Gaussian) and a mechanical embedding scheme. Frequencycalculations were performed to confirm that optimized TS structures have oneimaginary frequency that corresponds to the desired transition state vector. Singlepoint energy calculations were performed at the uB3LYP/Def2TZVP level. Snapshotsfor QM/MM calculations were obtained from classical MD trajectories, as describedbelow, and included all the protein residues, cofactors, counterions and watermolecules contained in a <3 Å shell around the protein structure. QM region atomswere defined based on previous studies by Thiel and co-workers.38 QM region included all atoms from the isoalloxazine ring of C4a-peroxyflavin, ketone substrates, the sidechain of R329, and the nicotinamide ring and the adjacent ribose of NADP+. The totalcharge of the QM region was +1. In the QM/MM optimizations the active site region tobe optimized included all QM atoms and all the residues and water molecules of theMM region within 6 Å from any atom in the QM region.Molecular Dynamics simulations were performed using the GPU code (pmemd)77 ofthe AMBER 16 package. Parameters for the different Criegee intermediates, cofactors
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and substrates were generated within the antechamber module using the general AMBER force field (gaff),78 with partial charges set to fit the electrostatic potential generated at the HF/6-31G(d) level by the RESP model.79 The charges were calculated according to the Merz–Singh–Kollman scheme80-81 using the Gaussian 09 package. Each protein was immersed in a pre-equilibrated truncated cuboid box with a 10 Å buffer of TIP3P82 water molecules using the leap module, resulting in the addition of around 15,000 solvent molecules. The systems were neutralized by addition of explicit counter ions (Na+ and Cl−). All subsequent calculations were done using the widely tested Stony Brook modification of the Amber99 force field (ff99sb).83 A two-stage geometry optimization approach was performed. The first stage minimizes the positions of solvent molecules and ions imposing positional restraints on the solute by a harmonic potential with a force constant of 500 kcal·mol-1·Å-2 and the second stage minimizes all the atoms in the simulation cell except those involved in the harmonic distance restraint. The systems were gently heated using six 50 ps steps, incrementing the temperature by 50 K for each step (0–300 K) under constant-volume and periodic-boundary conditions. Water molecules were treated with the SHAKE algorithm such that the angle between the hydrogen atoms was kept fixed. Long-range electrostatic effects were modelled using the particle-mesh-Ewald method.84 An 8 Å cutoff was applied to Lennard–Jones and electrostatic interactions. Harmonic restraints of 30 kcal·mol-1 were applied to the solute and the Andersen equilibration scheme was used to control and equalize the temperature. The time step was kept at 1 fs during the heating stages, allowing potential in homogeneities to self-adjust. Each system was then equilibrated for 2 ns with a 2 fs time step at a constant volume. Production trajectories were then run for an additional 500 ns under the same simulation conditions. References 1 Krow, G. The Baeyer–Villiger Oxidation of Ketones and Aldehydes. Org. React. 1993 (43) 251-798. 2 Renz, M; Meunier, B. 100 Years of Baeyer–Villiger Oxidations. Eur. J. Org. Chem. 1999  737-750. 3 Ten Brink, G-J; Arends, I; Sheldon, R. The Baeyer− Villiger Reaction: New Developments toward Greener Procedures. Chem. Rev. 2004 (104) 4105-4124. 4 Mihovilovic, MD; Rudroff, F; Grotzl, B. Enantioselective Baeyer-Villiger Oxidations. Curr. Org. Chem. 2004 (8) 1057-1069. 5 Bolm, C; Schlingloff, G; Weickhardt, K. Optically Active Lactones from a Baeyer–Villiger-Type Metal-Catalyzed Oxidation with Molecular Oxygen. Angew. Chem. Int. Ed. Engl. 1994 (33) 1848-1849. 6 Strukul, G. Transition Metal Catalysis in the Baeyer–Villiger Oxidation of Ketones. Angew. Chem. Int. Ed. Engl. 1998 (37) 1198-1209. 7 Frison, J-C; Palazzi, C; Bolm, C. Ligand Effects in Aluminium-Catalyzed Asymmetric Baeyer–Villiger Reactions. Tetrahedron 2006 (62) 6700-6706. 8 Malkov, AV; Friscourt, F; Bell, M; Swarbrick, ME; Kocovský, P. Enantioselective Baeyer–Villiger Oxidation Catalyzed by Palladium (II) Complexes with Chiral P, N-Ligands. J. Org. Chem. 2008 (73) 3996-4003. 
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